How Long Does It Take Antidepressants to Work? A Timeline

Antidepressants start working sooner than their reputation suggests. A meta-analysis of 28 randomized trials covering 5,872 patients found measurable improvement by the end of the first week, then continued gains at a decreasing rate for at least 6 weeks. What takes longer is enough change to feel like yourself again, which usually lands between weeks 4 and 6.

This guide lays out a realistic timeline, explains why early side effects arrive before the benefit, and covers what to do if the first medication falls short.

What Happens in the First Week?

Honestly, more happens than most people expect, though rarely enough to notice without paying attention.

The 2006 meta-analysis pooled data from 28 randomized controlled trials of selective serotonin reuptake inhibitors against placebo. Treatment with an SSRI rather than placebo was linked to clinical improvement by the end of week 1. The chance of a 50 percent drop in depression rating scores by week 1 was higher on medication, with a relative risk of 1.64.

That finding undercut a long-held belief about delayed antidepressant action. The old teaching said nothing happens for a month. But the data says the curve starts rising immediately, and simply keeps rising.

What patients report in week 1 is usually physical rather than emotional. Sleep gets a little deeper. Appetite returns. The morning feels marginally less heavy. Mood, motivation, and interest tend to follow later.

That’s also why we ask new patients to track two or three concrete things instead of asking themselves whether they feel better. Hours slept, meals eaten, and one activity you did anyway are easier to judge than a mood.

When Should You Expect Real Change?

Weeks 4 to 6 is the honest window for a noticeable difference. Or rather, that’s when most people notice. Something is generally happening well before that, which is the next section. And 8 to 12 weeks is the window for judging the medication.

The largest real-world study of antidepressant treatment, STAR*D, treated 2,876 outpatients with citalopram for up to 14 weeks using measurement-based care. Remission reached 28 percent on one scale and 33 percent on another, with a response rate of 47 percent. The mean final dose was 41.8 mg per day.

We compared the published timelines for the common antidepressants before building the table below, and the broad shape held across them. One line from that report matters more than the headline rates. A substantial portion of participants who achieved response or remission did so at or after 8 weeks of treatment. Stopping a medication at week 5 because it hasn’t worked yet risks abandoning something that would have worked at week 9. Which is a hard thing to hear at week 5.

Dose changes have their own rhythm. The sertraline label puts a floor under the pace: “the recommended interval between dose changes is one week”, based on the drug’s 24-hour elimination half-life. Each increase resets part of the clock.

How Do You Know It’s Actually Working?

Unfortunately, memory is a poor instrument when you’re depressed. Bad weeks feel like the whole month, and small gains disappear from the record.

That’s why STAR*D used measurement-based care, meaning symptoms and side effects were measured at every visit, with a written guide for when and how to change the dose based on those measures. The authors credited that approach for outcomes matching what tightly controlled efficacy trials produced, in a far messier real-world sample.

You can borrow the method. A short questionnaire at each visit gives you a number to compare against last month, instead of an impression. Between visits, three quick notes work well:

• Hours of sleep, and whether you woke rested.
• Whether you ate something like a normal meal.
• One thing you did that you’d have skipped a month ago.

Partial response is worth naming too. Plenty of patients land halfway: sleeping better, functioning at work, still flat by evening. That’s a signal to adjust rather than to give up on the medication. A dose increase, an added medication, or added therapy all target that gap.

Remission is the target we work toward, and it has a plain meaning. Symptoms fade far enough that they stop running your day. Response, by contrast, means symptoms dropped by about half. The difference matters, because people who stop at response relapse more often than people who reach remission.

Bring your notes to appointments. In our experience the patients who track something, anything, get to a working dose faster than the ones relying on memory.

Why Do Side Effects Show Up Before the Benefit?

Well, because the two effects run on different timescales.

An SSRI blocks the reuptake of serotonin within hours of the first dose, and serotonin receptors sit throughout your gut as well as your brain. Nausea, loose stools, restlessness, and disturbed sleep are the visible result. The antidepressant effect involves slower downstream adaptation, which is why it builds over weeks.

Real numbers help here. In pooled placebo-controlled trials, 12 percent of patients taking sertraline stopped because of an adverse reaction, against 4 percent on placebo. The common reasons were nausea at 3 percent, then diarrhea, agitation, and insomnia at about 2 percent each.

Most early side effects fade during weeks 2 and 3. Some don’t. Sexual side effects and weight change tend to persist, and they’re worth raising directly rather than waiting to be asked.

Here’s the practical rule we give patients. Frustrating side effects in week 1 usually deserve patience. Severe ones, or anything alarming, deserve a phone call the same day.

What If the First Antidepressant Doesn’t Work?

You still have good odds. And the numbers are worth knowing before you get discouraged.

STAR*D moved patients who didn’t reach remission through successive treatment steps. Remission rates were 36.8 percent at step one, 30.6 percent at step two, 13.7 percent at step three, and 13.0 percent at step four. The overall cumulative remission rate reached 67 percent.

Two lessons come out of that. First, most people who stick with treatment get there, though it may take more than one attempt. Second, the odds do fall with each step, which is why later steps often bring in different treatment options rather than a fourth or fifth pill.

At that stage, prescribers usually consider:

• Raising the dose within the approved range.
• Switching to a different antidepressant, sometimes in another class.
• Adding a second medication to augment the first.
• Adding or intensifying therapy.
• Considering TMS therapy or Spravato for treatment resistant depression.

Depression that hasn’t responded to two adequate trials has a name and a set of approved treatments. It isn’t a dead end, and it isn’t a verdict on you.

Does the Type of Antidepressant Change the Timeline?

Less than people assume. The broad shape holds across classes.

Selective serotonin reuptake inhibitors are the usual starting point. SNRIs work on serotonin and norepinephrine together. Atypical antidepressants such as bupropion and mirtazapine act on other systems, and each has a distinct side effect profile. Tricyclic antidepressants and monoamine oxidase inhibitors are older classes, still useful, though they carry more interactions and dietary rules.

Timelines look broadly similar, with two caveats. Sedating medications may improve sleep within days, which feels like fast progress. And any switch between classes involves a washout or cross-taper that adds time before the new drug reaches a therapeutic effect.

Anxiety changes the picture slightly. When an anxiety disorder sits alongside depression, prescribers often start lower and go slower, since early activation can spike anxiety. Antidepressant response for anxiety symptoms can also take longer than for mood.

One caution about switching too fast. Every change restarts the clock, and a patient who tries four medications in four months has not really tried any of them. Slow enough to be fair, quick enough to matter, is the balance your prescriber is trying to hold.

What Slows a Response Down?

Several things, and most are fixable.

• A dose that stayed at the starting level and was never raised.
• Missed doses, which are common and rarely mentioned.
• Regular alcohol use, which works against both sleep and mood.
• Untreated sleep apnea, thyroid problems, or anemia.
• An undiagnosed mood disorder such as bipolar disorder, where an antidepressant alone may not be the right approach.
• Ongoing chronic stress that no medication can outrun.

Medication management visits exist to catch these. Across our clinics in Richmond, Virginia, Dallas, Texas, Decatur, Georgia, and American Fork, Utah, a stalled response most often traces back to a dose that stayed at the starting point. The other common cause is a patient who stopped taking it during a rough week and didn’t want to say so.

We’re not going to scold you for that. Say it plainly, and the plan gets better.

When Should You Call Your Prescriber?

Sooner than you probably think. Call if:

• You have thoughts of harming yourself, at any point.
• Agitation, panic, or insomnia get worse rather than better.
• You feel unusually energetic, sleepless, or wired, which can signal a switch into mania.
• Side effects are severe or aren’t easing by week 3.
• Twelve weeks have passed with no meaningful change.

Between visits, the American Psychiatric Association and the National Institute of Mental Health both publish plain-language patient material on depression treatment that’s worth reading alongside your own notes.

More Questions About Antidepressant Timing

How long do I stay on it once it works?

Usually months at minimum, often longer, and it depends on how many episodes you’ve had. Stopping early is a common reason depression symptoms come back.

Do antidepressants work for postpartum depression?

They’re one option, and timing questions there are best answered by a prescriber who knows your history and whether you’re breastfeeding.

Will I feel like a different person?

Most patients describe feeling more like themselves rather than less. Flattened emotion happens for some people and is a reason to adjust the medication rather than to accept it.

Key Takeaways

• Measurable improvement appears by the end of week 1 in pooled SSRI trial data.
• Gains continue at a decreasing rate for at least 6 weeks.
• Noticeable change usually lands in weeks 4 to 6.
• A fair trial runs 8 to 12 weeks, since many STAR*D patients responded at or after week 8.
• Sleep and appetite often shift before mood does.
• Early side effects come from rapid serotonin changes, while benefit builds slowly.
• About 12 percent of sertraline patients stopped for an adverse reaction, against 4 percent on placebo.
• STAR*D remission was 36.8 percent at step one and 67 percent cumulatively across four steps.
• Stopping abruptly can bring discontinuation symptoms, so taper with your prescriber.

Talk With Foundation Medical Group

Waiting for a medication to work is its own kind of hard, especially when you’ve waited before. Our team offers psychiatric medication management with regular check-ins, so a stalled response gets caught in week 6 instead of month 6. We see patients in Richmond, VA and at our Texas, Georgia, and Utah offices, in person or by video.

Learn more about our psychiatric evaluation and about treatment options for depression when medication alone hasn’t been enough.

Sources

• Taylor et al, early onset of SSRI antidepressant action, Arch Gen Psychiatry 2006.
• Trivedi et al, citalopram outcomes in STAR*D, Am J Psychiatry 2006.
• Rush et al, acute and longer-term outcomes in STAR*D, Am J Psychiatry 2006.
• Sertraline (Zoloft) prescribing information, DailyMed.
• National Institute of Mental Health, Mental Health Medications.
• American Psychiatric Association, What Is Depression.